Sterling Capital Management LLC Biotechnology

Sterling Capital Management LLC

$7.74 Trillion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
BDTX Black Diamond Therapeutics, Inc.	$118M	$278,000 0.0% of portfolio	64	Q3 2024 New
MGNX Macrogenics Inc	$232M	$276,000 0.0% of portfolio	84	Q3 2024 New
TNYA Tenaya Therapeutics, Inc.	$86.5M	$276,000 0.0% of portfolio	143	Q3 2024 New
QSI Quantum Si Inc	$94.4M	$271,000 0.0% of portfolio	307	Q3 2024 New
KOD Kodiak Sciences Inc.	$286M	$266,000 0.0% of portfolio	102	Q3 2024 New
OCGN Ocugen, Inc.	$208M	$261,000 0.0% of portfolio	263	Q3 2024 New
RGLS Regulus Therapeutics Inc.	$22M	$261,000 0.0% of portfolio	166	Q3 2024 New
ADGI Adagio Therapeutics, Inc.	$505M	$257,000 0.0% of portfolio	252	Q3 2024 New
PBYI Puma Biotechnology, Inc.	$135M	$255,000 0.0% of portfolio	100	Q3 2024 New
IPSC Century Therapeutics, Inc.	$78.3M	$250,000 0.0% of portfolio	146	Q3 2024 New
CRDF Cardiff Oncology, Inc.	$137M	$246,000 0.0% of portfolio	92	Q3 2024 New
STTK Shattuck Labs, Inc.	$51.7M	$237,000 0.0% of portfolio	68	Q3 2024 New
RAPT Rapt Therapeutics, Inc.	$46.6M	$191,000 0.0% of portfolio	95	Q3 2024 New
CDXC Chroma Dex Corp.	$479M	$183,000 0.0% of portfolio	50	Q3 2024 New
PROK Prokidney Corp Ord Shs Cl A(Cy	$127M	$180,000 0.0% of portfolio	94	Q3 2024 New
HOWL Werewolf Therapeutics, Inc.	$60.5M	$172,000 0.0% of portfolio	81	Q3 2024 New
PEPG Pep Gen Inc.	$108M	$171,000 0.0% of portfolio	20	Q3 2024 New
VERU Veru Inc.	$49.7M	$161,000 0.0% of portfolio	210	Q3 2024 New
HLVX Hille Vax, Inc.	$64.5M	$153,000 0.0% of portfolio	87	Q3 2024 New
CADL Candel Therapeutics, Inc.	$130M	$139,000 0.0% of portfolio	20	Q3 2024 New
LCTX Lineage Cell Therapeutics, Inc.	$154M	$136,000 0.0% of portfolio	150	Q3 2024 New
SCPH Sc Pharmaceuticals Inc.	$107M	$132,000 0.0% of portfolio	29	Q3 2024 New
XFOR X4 Pharmaceuticals, Inc	$23.3M	$115,000 0.0% of portfolio	172	Q3 2024 New
GALT Galectin Therapeutics Inc	$172M	$105,000 0.0% of portfolio	38	Q3 2024 New
PRLD Prelude Therapeutics Inc	$38.6M	$87,000 0.0% of portfolio	42	Q3 2024 New
GLSI Greenwich Life Sciences, Inc.	$172M	$86,000 0.0% of portfolio	6	Q3 2024 New
OVID Ovid Therapeutics Inc.	$85.9M	$72,000 0.0% of portfolio	61	Q3 2024 New
INMB Inmune Bio, Inc.	$103M	$70,000 0.0% of portfolio	13	Q3 2024 New
ALXO Alx Oncology Holdings Inc	$54.6M	$62,000 0.0% of portfolio	34	Q3 2024 New
ELEV Elevation Oncology, Inc.	$13.7M	$59,000 0.0% of portfolio	98	Q3 2024 New
ATNM Actinium Pharmaceuticals, Inc.	$43.1M	$58,000 0.0% of portfolio	31	Q3 2024 New
ENOB Enochian Biosciences Inc	$244M	$43,000 0.0% of portfolio	89	Q3 2024 New
VRCA Verrica Pharmaceuticals Inc.	$327M	$28,000 0.0% of portfolio	19	Q3 2024 New
AVTE Aerovate Therapeutics, Inc.	$64.3M	$27,000 0.0% of portfolio	13	Q3 2024 New
LYRA Lyra Therapeutics, Inc.	$5.73M	$23,000 0.0% of portfolio	88	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Capital Management LLC with notifications on news.